ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
98.226,73
0,02%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) News

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DatumZeitQuelleÜberschriftSymbolFirma
04/01/202500h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
04/01/202500h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
04/01/202500h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
04/01/202500h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
30/12/202423h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
27/12/202422h46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
20/12/202400h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
20/12/202400h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
20/12/202400h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
11/12/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
26/11/202403h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
18/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VTYXVentyx Biosciences Inc
15/11/202422h59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202423h13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h05GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
15/10/202414h00GlobeNewswire Inc.Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024NASDAQ:VTYXVentyx Biosciences Inc
30/09/202422h40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTYXVentyx Biosciences Inc
23/09/202414h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
23/09/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
09/09/202422h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/09/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
30/08/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
30/08/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
28/08/202414h00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
13/08/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
13/08/202422h35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
08/08/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
08/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
TG
BAS
BASF
TG
CBK
Commerzbank
USOTC
DTEGY
Deutsche Telekom (QX)
FX
EURJPY
Euro vs Yen
TG
ALV
Allianz
COIN
XRPUSD
Ripple
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
TG
RHM
Rheinmetall
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten